Sign Up Today and Learn More About Front Range Biosciences Stock
Invest in or calculate the value of your shares in Front Range Biosciences or other pre-IPO companies through EquityZen's platform.
Front Range Biosciences Stock (FRRB)
Agricultural science for cannabis and hemp
About Front Range Biosciences Stock
Founded
2015
Headquarters
Boulder, CO, US
Total Funding
14.6M
Industries
Software, Artificial Intelligence, Financial Services
Front Range Biosciences Press Mentions
Stay in the know about the latest news on Front Range Biosciences
Characterization of plant cultivars based on terpene synthase gene profiles
patents • Feb 09, 2025
Compositions and methods for obtaining plant cultivars with desired terpene …
patents • Apr 13, 2024
Cannabis plant named 'lpa004'
patents • Apr 13, 2024
Methods and compositions for pathogen detection in plants
patents • Apr 13, 2024
Characterization of cannabis cultivars based on terpene synthase gene profiles
patents • Apr 13, 2024
Front Range Biosciences Management
Leadership team at Front Range Biosciences
CEO, Founder
Jonathan Vaught
COO, Founder
Nick Hofmeister
Join now and verify your accreditation status to gain access to:
- Front Range Biosciences Current Valuation
- Front Range Biosciences Stock Price
- Front Range Biosciences Management
- Available deals in Front Range Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Front Range Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Front Range Biosciences Revenue and Financials
- Front Range Biosciences Highlights
- Front Range Biosciences Business Model
- Front Range Biosciences Risk Factors
- Front Range Biosciences Research Report from SACRA Research
Trading Front Range Biosciences Stock
How to invest in Front Range Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Front Range Biosciences through EquityZen funds. These investments are made available by existing Front Range Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Front Range Biosciences stock?
Shareholders can sell their Front Range Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
